Consumer Healthcare Market by Product (Dietary Supplements, OTC Pharmaceuticals), Distribution (Departmental Stores, Independent Retailers, Pharmacies or Drugstores) - Global Forecast 2024-2030

Consumer Healthcare Market by Product (Dietary Supplements, OTC Pharmaceuticals), Distribution (Departmental Stores, Independent Retailers, Pharmacies or Drugstores) - Global Forecast 2024-2030


The Consumer Healthcare Market size was estimated at USD 333.03 billion in 2023 and expected to reach USD 356.94 billion in 2024, at a CAGR 7.38% to reach USD 548.31 billion by 2030.Consumer healthcare covers any oral care, nutritional care, skin care, or other cosmetic or healthcare product or device which is available to individuals with and without a prescription. Healthcare products under this branch of healthcare are produced using random samples and personalized healthcare assessments focusing on understanding and treating the deep-rooted cases of a common skin and body condition. Consumer healthcare products are exclusively available through online retailers, enabling consumers to take control of their health with a solution delivered right to their front door. The rising inclination of consumers towards self-medication products, with the availability of private-label healthcare products, elevates the consumer healthcare market development. However, the increased accessibility to counterfeit products and misuse of consumer healthcare products severely impede their adoption among new users. The awareness of the safety of preventative and wellness products, driven by testing and approval from global healthcare authorities, is creating the potential for the further expansion of the consumer healthcare market.Regional InsightsThe Asia-Pacific portrays a highly growing potential in the consumer health market, driven by the presence of local conglomerates and domestic consumer packaged goods (CPG) companies with stronger and deeper penetration and geographical footprint. The Asia-Pacific and Middle East & Africa are major sources of raw materials, such as ginkgo biloba and Arabian spice blends, and an inspiration for new product lines, such as herbal tonics and drinks based on traditional Chinese and Turkish medicine (TCM). The American and European region is home to well-established global companies focused on building an innovative portfolio of trusted personal health products that use cutting-edge science and technology. Availability of products through various eCommerce channels and increasing demand for premium consumer healthcare products, both imported and domestic, are driving the popularity of consumer health products in emerging countries of Asia and the Middle East.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Consumer Healthcare Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Consumer Healthcare Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Consumer Healthcare Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories Inc., Alembic Pharmaceuticals Ltd., Alkem Laboratories Limited, AMCO Proteins, American Health Inc., Amway Corporation by Alticor corporation, Axtria Inc., BASF SE, Bayer AG, Bionova Lifesciences by Pragati Biocare Pvt. Ltd., Boehringer Ingelheim International GmbH, Cipla, Inc., Dr. Reddy's Laboratories, Eli Lilly and Company, Endo Pharmaceuticals PLC by DuPont de Nemours, Inc., Gemini Pharmaceuticals Inc., Glanbia PLC, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Henin Lukinz Pvt. Ltd., Herbalife Ltd., Hetero Drugs Ltd., Himalaya Wellness Company, Iovate Health Sciences International Inc., Ipsen S.A., Johnson & Johnson Services, Inc., Koninklijke DSM N.V., Lonza Group Ltd., Lupin Limited, Mankind Pharma, MusclePharm Corporation, Mylan Pharmaceuticals Pvt. Ltd. by Viatris, Nature's Bounty, Inc. by Nestlé S.A., Novartis AG, Omega Protein Corporation, Pfizer Inc., Piramal Group, Procter & Gamble Company, PureTek Corporation, QuestNutrition, Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Limited, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Ventus Pharmaceuticals Private Limited, and Zoic Biotech Private Limited.

Market Segmentation & Coverage


This research report categorizes the Consumer Healthcare Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Dietary Supplements
OTC Pharmaceuticals
Distribution
Departmental Stores
Independent Retailers
Pharmacies or Drugstores
Specialist Retailers
Supermarkets or Hypermarkets
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Consumer Healthcare Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Consumer Healthcare Market?
3. What are the technology trends and regulatory frameworks in the Consumer Healthcare Market?
4. What is the market share of the leading vendors in the Consumer Healthcare Market?
5. Which modes and strategic moves are suitable for entering the Consumer Healthcare Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Consumer Healthcare Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising geriatric population and inclination of consumers towards self-medication products
5.1.1.2. Government support to offer affordable and improved access to healthcare
5.1.1.3. Growing adoption of private labels consumer healthcare products
5.1.2. Restraints
5.1.2.1. Availability of counterfeit products that lack active pharmaceutical ingredients
5.1.3. Opportunities
5.1.3.1. Increasing approval rate of wellness and preventive medicines
5.1.3.2. Rapid growth of online pharmacies and improved availability through online platforms
5.1.4. Challenges
5.1.4.1. Concerns associated with abuse and misuse of consumer healthcare products
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Consumer Healthcare Market, by Product
6.1. Introduction
6.2. Dietary Supplements
6.3. OTC Pharmaceuticals
7. Consumer Healthcare Market, by Distribution
7.1. Introduction
7.2. Departmental Stores
7.3. Independent Retailers
7.4. Pharmacies or Drugstores
7.5. Specialist Retailers
7.6. Supermarkets or Hypermarkets
8. Americas Consumer Healthcare Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Consumer Healthcare Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Consumer Healthcare Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
11.3.1. Merger & Acquisition
11.3.1.1. SPE Capital acquires majority stake in Vital, the leading nutritional supplements company in Tunisia
11.3.1.2. Cipla Health to buy nutritional supplement brand Endura Mass
11.3.1.3. Orkla Health acquires Healthspan
11.3.2. Agreement, Collaboration, & Partnership
11.3.2.1. LBB Specialties and DSM announce partnership for North America Dietary Supplements Distribution
11.3.2.2. Cosmos Health to Launch Sky Premium Life Nutritional Supplement Products in Germany and Austria via Amazon and Ebay
11.3.3. New Product Launch & Enhancement
11.3.3.1. Nutrilitius expands portfolio with launch of new range of nutraceuticals, Unleashing the Power of Food Science & Technology
11.3.3.2. health supplements: Tata Consumer enters health supplements segment, launches plant protein powder
11.3.3.3. Amway India launches nutrition supplements in gummies and jelly strips
11.3.4. Investment & Funding
11.3.4.1. Wellbeing Nutrition raises $2.2 million led by Fireside Ventures
11.3.5. Award, Recognition, & Expansion
11.3.5.1. Bayer launches Consumer Health division in India
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Abbott Laboratories Inc.
12.1.2. Alembic Pharmaceuticals Ltd.
12.1.3. Alkem Laboratories Limited
12.1.4. AMCO Proteins
12.1.5. American Health Inc.
12.1.6. Amway Corporation by Alticor corporation
12.1.7. Axtria Inc.
12.1.8. BASF SE
12.1.9. Bayer AG
12.1.10. Bionova Lifesciences by Pragati Biocare Pvt. Ltd.
12.1.11. Boehringer Ingelheim International GmbH
12.1.12. Cipla, Inc.
12.1.13. Dr. Reddy's Laboratories
12.1.14. Eli Lilly and Company
12.1.15. Endo Pharmaceuticals PLC by DuPont de Nemours, Inc.
12.1.16. Gemini Pharmaceuticals Inc.
12.1.17. Glanbia PLC
12.1.18. GlaxoSmithKline PLC
12.1.19. Glenmark Pharmaceuticals Ltd.
12.1.20. Henin Lukinz Pvt. Ltd.
12.1.21. Herbalife Ltd.
12.1.22. Hetero Drugs Ltd.
12.1.23. Himalaya Wellness Company
12.1.24. Iovate Health Sciences International Inc.
12.1.25. Ipsen S.A.
12.1.26. Johnson & Johnson Services, Inc.
12.1.27. Koninklijke DSM N.V.
12.1.28. Lonza Group Ltd.
12.1.29. Lupin Limited
12.1.30. Mankind Pharma
12.1.31. MusclePharm Corporation
12.1.32. Mylan Pharmaceuticals Pvt. Ltd. by Viatris
12.1.33. Nature's Bounty, Inc. by Nestlé S.A.
12.1.34. Novartis AG
12.1.35. Omega Protein Corporation
12.1.36. Pfizer Inc.
12.1.37. Piramal Group
12.1.38. Procter & Gamble Company
12.1.39. PureTek Corporation
12.1.40. QuestNutrition
12.1.41. Reckitt Benckiser Group PLC
12.1.42. Sanofi S.A.
12.1.43. Sun Pharmaceutical Industries Limited
12.1.44. Takeda Pharmaceutical Company Limited
12.1.45. Teva Pharmaceutical Industries Ltd.
12.1.46. Ventus Pharmaceuticals Private Limited
12.1.47. Zoic Biotech Private Limited
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
FIGURE 1. CONSUMER HEALTHCARE MARKET RESEARCH PROCESS
FIGURE 2. CONSUMER HEALTHCARE MARKET SIZE, 2023 VS 2030
FIGURE 3. CONSUMER HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CONSUMER HEALTHCARE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CONSUMER HEALTHCARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CONSUMER HEALTHCARE MARKET DYNAMICS
FIGURE 7. CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. CONSUMER HEALTHCARE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 10. CONSUMER HEALTHCARE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES CONSUMER HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CONSUMER HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. CONSUMER HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. CONSUMER HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings